Showing results (1521-1530 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic ControlChristopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.The Oncologist|February 24, 2019
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal CancerCarolina Reyes, Nicole M Engel-Nitz, Stacey DaCosta Byfield, et al.The Oncologist|February 28, 2019
Predictors of Success of Phase II Pediatric Oncology Clinical TrialsLaura Franshaw, Maria Tsoli, Jennifer Byrne, et al.The Oncologist|February 21, 2019
A Pairwise Meta-Analysis of Induction Chemotherapy in Nasopharyngeal CarcinomaPu-Yun OuYang, Xiao-Min Zhang, Xing-Sheng Qiu, et al.The Oncologist|November 25, 2018
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral NeuropathyLara Sánchez-Barroso, Maria Apellaniz-Ruiz, Gerardo Gutiérrez-Gutiérrez, et al.The Oncologist|March 8, 2019
Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory PapillomatosisBen C Creelan, M Usman Ahmad, Frank J Kaszuba, et al.The Oncologist|March 8, 2019
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and CanadaBrian Chen, Sumimasa Nagai, James O Armitage, et al.The Oncologist|February 26, 2021
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint InhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.The Oncologist|February 25, 2021
Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal CancerIbrahim Halil Sahin, Subir Goyal, Yoanna Pumpalova, et al.Pageof 571